Steve E. Krognes
CIK: 0001666236
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (40 total)
- Sep 16, 2026GH
Guardant Health, Inc.
Sale(S)Direct1.3K shares at avg. $176.34$229K - Sep 16, 2026GH
Guardant Health, Inc.
Sale(S)Direct1.1K shares at avg. $174.46$192K - Sep 16, 2026GH
Guardant Health, Inc.
Sale(S)Direct3.3K shares at avg. $175.42$579K - Sep 16, 2026GH
Guardant Health, Inc.
Sale(S)Direct971 shares at avg. $177.48$172K - Jun 30, 2026GH
Guardant Health, Inc.
Exercise(M)Direct155 shares- - Jun 17, 2026GH
Guardant Health, Inc.
Award(A)DirectRestricted Stock Units
2.7K shares- - Jun 17, 2026GH
Guardant Health, Inc.
Exercise(M)Direct4.2K shares- - Jun 11, 2026PLRX
PLIANT THERAPEUTICS, INC.
Award(A)DirectStock Option (Right to Buy)
70K shares- - Jun 4, 2026GH
Guardant Health, Inc.
Sale(S)Direct9.3K shares at avg. $132.51$1.2M - Jun 3, 2026DNLI
Denali Therapeutics Inc.
Award(A)Direct6.4K shares- - May 31, 2026GH
Guardant Health, Inc.
Exercise(M)Direct154 shares- - Apr 30, 2026GH
Guardant Health, Inc.
Exercise(M)Direct154 shares- - Mar 31, 2026GH
Guardant Health, Inc.
Exercise(M)Direct155 shares- - Feb 28, 2026GH
Guardant Health, Inc.
Exercise(M)Direct154 shares- - Jan 31, 2026GH
Guardant Health, Inc.
Exercise(M)Direct154 shares- - Dec 31, 2025GH
Guardant Health, Inc.
Exercise(M)Direct154 shares- - Nov 30, 2025GH
Guardant Health, Inc.
Exercise(M)Direct155 shares- - Oct 31, 2025GH
Guardant Health, Inc.
Exercise(M)Direct154 shares- - Sep 30, 2025GH
Guardant Health, Inc.
Exercise(M)Direct154 shares- - Aug 31, 2025GH
Guardant Health, Inc.
Exercise(M)Direct155 shares- - Jul 31, 2025GH
Guardant Health, Inc.
Exercise(M)Direct154 shares- - Jun 30, 2025GH
Guardant Health, Inc.
Exercise(M)Direct154 shares- - Jun 18, 2025GH
Guardant Health, Inc.
Award(A)DirectRestricted Stock Units
4.2K shares- - Jun 18, 2025GH
Guardant Health, Inc.
Award(A)DirectStock Option (Right to Buy)
6.8K shares- - Jun 12, 2025GH
Guardant Health, Inc.
Exercise(M)Direct6.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 16, 2026 |  GH Guardant Health, Inc. | Sale(S) | 1,300 | $176.34 | $229,236 | Direct |
| Sep 16, 2026 | GH Guardant Health, Inc. | Sale(S) | 1,103 | $174.46 | $192,432 | Direct |
| Sep 16, 2026 | GH Guardant Health, Inc. | Sale(S) | 3,300 | $175.42 | $578,888 | Direct |
| Sep 16, 2026 | GH Guardant Health, Inc. | Sale(S) | 971 | $177.48 | $172,330 | Direct |
| Jun 30, 2026 | GH Guardant Health, Inc. | Exercise(M) | 155 | - | $0 | Direct |
| Jun 17, 2026 | GH Guardant Health, Inc. | Award(A) Restricted Stock Units | 2,711 | - | - | Direct |
| Jun 17, 2026 | GH Guardant Health, Inc. | Exercise(M) | 4,203 | - | $0 | Direct |
| Jun 11, 2026 |  PLRX PLIANT THERAPEUTICS, INC. | Award(A) Stock Option (Right to Buy) | 70,000 | - | - | Direct |
| Jun 4, 2026 | GH Guardant Health, Inc. | Sale(S) | 9,294 | $132.51 | $1,231,522 | Direct |
| Jun 3, 2026 |  DNLI Denali Therapeutics Inc. | Award(A) | 6,408 | - | $0 | Direct |
| May 31, 2026 | GH Guardant Health, Inc. | Exercise(M) | 154 | - | $0 | Direct |
| Apr 30, 2026 | GH Guardant Health, Inc. | Exercise(M) | 154 | - | $0 | Direct |
| Mar 31, 2026 | GH Guardant Health, Inc. | Exercise(M) | 155 | - | $0 | Direct |
| Feb 28, 2026 | GH Guardant Health, Inc. | Exercise(M) | 154 | - | $0 | Direct |
| Jan 31, 2026 | GH Guardant Health, Inc. | Exercise(M) | 154 | - | $0 | Direct |
| Dec 31, 2025 | GH Guardant Health, Inc. | Exercise(M) | 154 | - | $0 | Direct |
| Nov 30, 2025 | GH Guardant Health, Inc. | Exercise(M) | 155 | - | - | Direct |
| Oct 31, 2025 | GH Guardant Health, Inc. | Exercise(M) | 154 | - | - | Direct |
| Sep 30, 2025 | GH Guardant Health, Inc. | Exercise(M) | 154 | - | - | Direct |
| Aug 31, 2025 | GH Guardant Health, Inc. | Exercise(M) | 155 | - | - | Direct |
| Jul 31, 2025 | GH Guardant Health, Inc. | Exercise(M) | 154 | - | - | Direct |
| Jun 30, 2025 | GH Guardant Health, Inc. | Exercise(M) | 154 | - | - | Direct |
| Jun 18, 2025 | GH Guardant Health, Inc. | Award(A) Restricted Stock Units | 4,203 | - | - | Direct |
| Jun 18, 2025 | GH Guardant Health, Inc. | Award(A) Stock Option (Right to Buy) | 6,833 | - | - | Direct |
| Jun 12, 2025 | GH Guardant Health, Inc. | Exercise(M) | 6,674 | - | - | Direct |
1-25 of 40 transactions
About Krognes Steve E.
Krognes Steve E. (SEC CIK 0001666236) files insider reports with the SEC as Director of Guardant Health, Inc. (GH), Director of PLIANT THERAPEUTICS, INC. (PLRX) and Director of Denali Therapeutics Inc. (DNLI).
Signal8 holds 35 ownership filings by Krognes Steve E., all Form 4s, filed between Sep 3, 2024 and Sep 17, 2026. Those filings report 40 transactions, from Aug 31, 2024 to Sep 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Krognes Steve E.'s filings is in PALO ALTO, CA.
Recent filings by Krognes Steve E.
- Sep 16, 2026: Open-market sales of GH shares (4 lines, Form 4, code S).
- Jun 30, 2026: Option exercise of GH shares (Form 4, code M).
- Jun 17, 2026: Grant or award of GH derivative securities (Form 4, code A).
- Jun 17, 2026: Option exercise of GH shares (Form 4, code M).
- Jun 11, 2026: Grant or award of PLRX derivative securities (Form 4, code A).
Other insiders filing for Guardant Health, Inc. (GH)
- MIGNONE ROBERTO, Director
- Hidalgo Medina Manuel, Director
- Tariq Musa, Director
- Azar Alex M II, Director
- Saia John G., Chief Legal Officer
- Monroe Terilyn J., Chief People Officer